Abstract
Should we treat it with anti‐TNFα agents or is TNFα only one piece of the puzzle?
MeSH terms
-
Animals
-
Antibodies, Monoclonal / therapeutic use
-
Etanercept
-
Humans
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Intervertebral Disc / immunology
-
Intervertebral Disc Displacement / complications*
-
Intervertebral Disc Displacement / drug therapy
-
Intervertebral Disc Displacement / immunology
-
Models, Animal
-
Radiculopathy / complications*
-
Radiculopathy / drug therapy
-
Radiculopathy / immunology
-
Randomized Controlled Trials as Topic
-
Receptors, Tumor Necrosis Factor / immunology
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Tumor Necrosis Factor-alpha / adverse effects
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Tumor Necrosis Factor-alpha / physiology
Substances
-
Antibodies, Monoclonal
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Etanercept